510(k) · Cleared
ClearedSplit Septum Injection Sites
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Fresenius Medical Care North America · FPA Set, Administration, Intravascular
Cleared on Jul 16, 2004 as substantially equivalent to K962081 (National Medical Care, Medical Products Div., Inc., 1996) and 5 other predicates after an 85-day review. Its family tree reaches back 2 generations to 1996.
- Decided
- Jul 16, 2004
- Review
- 85 days
- Class
- Class II
- Product code
- FPA
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 2 generations to K962081 (1996). 6 ancestors in all. No later device cites it as a predicate yet.
- Root · 2 generations backK962081 Combilines Hemodialysis Blood Tubing SetNational Medical Care, Medical Products Div., Inc. · 1996 · Recalled
- 1 generation backK012242 Fresenius Arterial Bloodline Sets for Hemodialysis, Fresenius Combi…Fresenius Medical Care North America · 2001
- This deviceK041042 Split Septum Injection SitesFresenius Medical Care North America · 2004
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K962081 | Combilines Hemodialysis Blood Tubing Set | National Medical Care, Medical Products Div., Inc. | 1996 | 2 |
| −1 | K012242 | Fresenius Arterial Bloodline Sets for Hemodialysis, Fresenius Combi Sets… | Fresenius Medical Care North America | 2001 | — |
| 0 (this device) | K041042 | Split Septum Injection Sites | Fresenius Medical Care North America | 2004 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 2 | 0 |
| 2000 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FPA device
- #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K962081 | Combilines Hemodialysis Blood Tubing SetSummary page 1…ion Valve - Class II Device Product Code and Panel Code: KOC, 78 and FJK, 78 Predicate Device(s): * Fresenius CombiSets® Hemodialysis Blood Tubing Sets; K962081, SE 11/01/96 * Fresenius CombiSets® Hemodialysis Blood Tubing Sets; KOO1 107, SE 06/23/00 * Fresenius CombiSets… | 1996 |
| * | K001107 | Fresenius Combilines Low Volume Blood Tubing Set, Models 03-2291 (Post Pump) and 03-2292… | 2000 |
| * | K000451 | Fresenius Combillines Single Needle Blood Tubing Set, Catalog #03-2290Summary page 1…962081, SE 11/01/96 * Fresenius CombiSets® Hemodialysis Blood Tubing Sets; KOO1 107, SE 06/23/00 * Fresenius CombiSets® Hemodialysis Blood Tubing Sets; K000451, SE 05/09/00 * Fresenius Arterial Blood Tubing Sets; K971313, SE 10/27/97 * Fresenius Venous Blood Tubing Sets;… | 2000 |
| * | K971313 | NMC Hemodialysis Arterial Blood Tubing SetSummary page 1…Tubing Sets; KOO1 107, SE 06/23/00 * Fresenius CombiSets® Hemodialysis Blood Tubing Sets; K000451, SE 05/09/00 * Fresenius Arterial Blood Tubing Sets; K971313, SE 10/27/97 * Fresenius Venous Blood Tubing Sets; K971687, SE 07/29/97 * Fresenius Single Use Arterial Bloodli… | 1997 |
| * | K971687 | Hemodialysis Venous Blood Tubing Set or Similar Trade NameSummary page 1…Hemodialysis Blood Tubing Sets; K000451, SE 05/09/00 * Fresenius Arterial Blood Tubing Sets; K971313, SE 10/27/97 * Fresenius Venous Blood Tubing Sets; K971687, SE 07/29/97 * Fresenius Single Use Arterial Bloodline Sets with Alternate Pump Segment Material, K012242,… | 1997 |
| * | K012242 | Fresenius Arterial Bloodline Sets for Hemodialysis, Fresenius Combi Sets Hemodialysis…Summary page 1…0/27/97 * Fresenius Venous Blood Tubing Sets; K971687, SE 07/29/97 * Fresenius Single Use Arterial Bloodline Sets with Alternate Pump Segment Material, K012242, 08/16/01 Description: The Split Septum Injection Sites are designed for use during hemodialysis with eit… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 4.8 years on median.
- 1 of the 6 ancestors has a recall of any class.
- 1 other device also cites its predicate K962081.
How does its category compare?
All FPA devicesFPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · FPA
11in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FPA
225in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FPA
98in 2025
Class I (17 since 2007) Class II/III not classified
Adverse event reports per year · FPA
34,506in 2025
MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 16 | 75 | 17 | 1,499 |
| 2008 | 18 | 89 | 15 | 1,941 |
| 2009 | 10 | 166 | 166 | 2,512 |
| 2010 | 23 | 120 | 58 | 2,537 |
| 2011 | 12 | 87 | 28 | 4,407 |
| 2012 | 21 | 96 | 16 (4) | 4,930 |
| 2013 | 13 | 90 | 64 | 4,651 |
| 2014 | 22 | 89 | 24 | 4,695 |
| 2015 | 17 | 123 | 6 | 6,625 |
| 2016 | 12 | 195 | 10 | 8,470 |
| 2017 | 17 | 240 | 13 | 6,462 |
| 2018 | 4 | 177 | 4 | 6,574 |
| 2019 | 7 | 161 | 13 | 11,227 |
| 2020 | 10 | 327 | 107 | 9,563 |
| 2021 | 13 | 186 | 1 | 10,414 |
| 2022 | 14 | 213 | 9 (5) | 13,393 |
| 2023 | 14 | 340 | 12 (4) | 10,916 |
| 2024 | 7 | 244 | 13 (1) | 47,210 |
| 2025 | 11 | 225 | 98 (1) | 34,506 |
| 2026 | 5 | 266 | 10 (2) | — |
What is it indicated for?
The Fresenius CombSets are intended for use as the extracorporeal blood circuit during Hemodialysis. They are intended for single use only. The CombiSets are indicated for use with conventional and high flux negative pressure hemodialyzer equipment. The Fresenius Venous Bloodline is intended for use as the extracorporeal blood circuit during Hemodialysis. It is intended for single only use. The Hemodialysis Venous Blood Tubing Set is indicated for use…
Read the full statement (117 words)
The Fresenius CombSets are intended for use as the extracorporeal blood circuit during Hemodialysis. They are intended for single use only. The CombiSets are indicated for use with conventional and high flux negative pressure hemodialyzer equipment.
The Fresenius Venous Bloodline is intended for use as the extracorporeal blood circuit during Hemodialysis. It is intended for single only use. The Hemodialysis Venous Blood Tubing Set is indicated for use with conventional and high flux negative pressure hemodialyzer equipment.
The Fresenius Arterial Bloodline is intended for use as the extracorporeal blood circuit during Hemodialysis. It is intended for single only use. The Fresenius Arterial Bloodline is intended to for use with conventional and high flux negative pressure hemodialyzer equipment.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K041042 · printed Nov 6, 2026
Cite this page
510(k) Report. “K041042: Split Septum Injection Sites.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K041042
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026